Resistance of Cancer Cells to CTL-Mediated Immunotherapy: 7 (Resistance to Targeted Anti-Cancer Therapeutics, 7) - Image 1

£76.02

Springer Resistance of Cancer Cells to CTL-Mediated Immunotherapy: 7 (Resistance to Targeted Anti-Cancer Therapeutics, 7)

Name: Resistance of Cancer Cells to CTL-Mediated Immunotherapy: 7 (Resistance to Targeted Anti-Cancer Therapeutics, 7)
Brand: Springer
Price: 76.02 GBP
Availability: InStock

Diseases & Disorders

About as cheap as it gets. The only time it was cheaper was 3 months ago.

£76 today · all-time low £76 (Mar 2026) · usually the usual

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 56 days • 56 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 56 days • 1 price levels

Days at Price

Price Analysis

Most common price: £76 (56 days, 100.0%)

Price range: £76 - £76

Price levels: 1 different prices over 56 days

Description

This comprehensive volume explores the latest research on the mechanisms of resistance in cancer cells to CTL-mediated immunotherapy. Chapter topics discuss cell-mediated immunity as the result of cytotoxic T-lymphocytes (CTL) directed specifically against cancer cells. In addition, the volume reviews how CTL mediate the cytotoxic activity, in large part, by the indication of apoptosis; hence, tumor cells develop anti-apoptotic mechanisms and thereby, resist CTL-induced apoptosis. In order for CTL-mediated antitumor immunotherapy to be effective, it is essential that agents directed against the resistant tumor cells sensitized cancer cells for CTL-mediated apoptosis. Examples of such agents discussed in the volume include are HDAC inhibitors, proteasome inhibitors, Bcl-2 family inhibitors, PARP, antibodies, and more.

Product Specifications

Brand: Springer
Format: hardcover
ASIN: 3319178067
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders
Domain: Amazon UK
Release Date: 30 June 2015
Listed Since: 12 March 2015

Barcode

No barcode data available

Springer Resistance of Cancer Cells to CTL-Mediated Immunotherapy: 7 (Resistance to Targeted Anti-Cancer Therapeutics, 7)

About as cheap as it gets. The only time it was cheaper was 3 months ago.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Current Immunotherapeutic Strategies in Cancer: 214 (Recent Results in Cancer Research, 214)

Humana - T Cell Based Cancer Immunotherapies Book

Developments in T Cell Based Cancer Immunotherapies (Cancer Drug Discovery and Development)

Springer - Immunotherapy of Cancer: An Innovative Treatment

Cancer Immunotherapy: Methods and Protocols: 2748 (Methods in Molecular Biology, 2748)

Immunotherapy of Cancer: Methods and Protocols: 651 (Methods in Molecular Biology, 651)

Progress in Cancer Immunotherapy: 909 (Advances in Experimental Medicine and Biology, 909)

Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors

Immunotherapy: 1342 (Advances in Experimental Medicine and Biology, 1342)

Targeted Cancer Immune Therapy

Tumor Antigens Recognized by T Cells and Antibodies: 3 (Tumour Immunology and Immunotherapy Series)

Cancer Immunology: A Translational Medicine Context

Cancer Immunology: Bench to Bedside Immunotherapy of Cancers

Cancer Immunology: Bench to Bedside Immunotherapy of Cancers

Cell Reprogramming for Immunotherapy: Methods and Protocols: 2097 (Methods in Molecular Biology, 2097)

Critical Developments in Cancer Immunotherapy

General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology

Immunotherapy in Translational Cancer Research (Translational Oncology)

Tumor Immunology and Cancer Therapy: 61

Immune-based Cancer Treatment: The T Iymphocyte Response

Springer - Tumor-Induced Immune Suppression Book

Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research, 27)

Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research, 27)

Tumor Immunology: Methods and Protocols: 1393 (Methods in Molecular Biology, 1393)